NH TherAguix is a clinical stage company.
NH TherAguix has raised €13M across 1 funding round from 1 investor, most recently a Series A round in Apr 2019. Based in Villeurbanne, France; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Series A |
| €13M |
| BPI France |
| View deal → |
